{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:57:46Z","timestamp":1788919066379,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jacc.2009.05.074","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T00:35:33Z","timestamp":1257986133000},"page":"1935-1945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["The Relative Efficacy and Safety of Clopidogrel in Women and Men"],"prefix":"10.1016","volume":"54","author":[{"given":"Jeffrey S.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamir R.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Steinhubl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Topol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.05.074_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.RES.0000264509.36234.51","article-title":"Clinical aspects of platelet inhibitors and thrombus formation","volume":"100","author":"Meadows","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2009.05.074_bib2","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib3","doi-asserted-by":"crossref","first-page":"28B","DOI":"10.1016\/0002-9149(91)90382-U","article-title":"Coronary thrombosis: pathogenesis and clinical manifestations","volume":"68","author":"Falk","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2009.05.074_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.05.074_bib8","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2009.05.074_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.074_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.074_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0049-3848(86)90029-0","article-title":"Sex-related differences in the effects of aspirin on the interaction of platelets with subendothelium","volume":"44","author":"Escolar","year":"1986","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2009.05.074_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJMe058051","article-title":"The puzzle of aspirin and sex","volume":"352","author":"Levin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0002-9149(02)02251-8","article-title":"Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb\/IIIa inhibitors","volume":"89","author":"Iakovou","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.074_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.074_bib16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.074_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib19","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.074_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2009.05.074_bib22","doi-asserted-by":"crossref","first-page":"549S","DOI":"10.1378\/chest.126.3_suppl.549S","article-title":"Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Menon","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2009.05.074_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib24","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","article-title":"Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases","volume":"26","author":"Jochmann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.05.074_bib25","series-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","author":"Deeks","year":"2001"},{"key":"10.1016\/j.jacc.2009.05.074_bib26","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","article-title":"Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.074_bib27","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jacc.2009.05.074_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progr Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2009.05.074_bib29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00129784-200707040-00006","article-title":"Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials","volume":"7","author":"Helton","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2009.05.074_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0002-9343(91)90130-P","article-title":"Stroke prevention in women: role of aspirin versus ticlopidine","volume":"91","author":"Hershey","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2009.05.074_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0735-1097(00)00746-4","article-title":"Clinical benefit of glycoprotein IIb\/IIIa blockade with abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials","volume":"36","author":"Cho","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0735-1097(02)02120-4","article-title":"Is glycoprotein IIb\/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?","volume":"40","author":"Fernandes","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib35","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","article-title":"Ticlopidine and clopidogrel","volume":"100","author":"Quinn","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib36","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1161\/CIRCULATIONAHA.106.675991","article-title":"Variable platelet response to aspirin and clopidogrel in atherothrombotic disease","volume":"115","author":"Maree","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib37","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib38","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib40","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib41","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment","volume":"43","author":"Chen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.074_bib44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1345\/aph.1H621","article-title":"Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction","volume":"41","author":"Dorsch","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2009.05.074_bib45","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2009.05.074_bib46","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.05.074_bib47","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.106.620815","article-title":"Sex differences in major bleeding with glycoprotein IIb\/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA guidelines) initiative","volume":"114","author":"Alexander","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.074_bib48","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.074_bib49","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.1980.03310110019020","article-title":"Predictors of bleeding during heparin therapy","volume":"244","author":"Walker","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.074_bib50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709028411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709028411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:34:41Z","timestamp":1760013281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709028411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":50,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0735109709028411"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.074","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Relative Efficacy and Safety of Clopidogrel in Women and Men","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.06.044","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}